We are live on
!
Find out more
EOJOAM
E. Ohman J:or Asset Management Portfolio holdings
AUM
$4.3B
1-Year Est. Return
29.55%
This Fund
S&P 500
This Quarter
Est. Return
+23.95%
1 Year Est. Return
+29.55%
3 Year Est. Return
+110.24%
5 Year Est. Return
+144.75%
10 Year Est. Return
+695.34%
AUM
$1.74B
AUM Growth
+$379M
(+28%)
Cap. Flow
+$80.9M
Cap. Flow
% of AUM
4.64%
Top 10 Holdings %
Top 10 Hldgs %
35.88%
Holding
472
New
31
Increased
172
Reduced
26
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Akamai
AKAM
|
+$21.7M |
| 2 |
NUVA
NuVasive, Inc.
NUVA
|
+$15.6M |
| 3 |
Lamb Weston
LW
|
+$15.1M |
| 4 |
ONEM
1Life Healthcare
ONEM
|
+$12.3M |
| 5 |
Alibaba
BABA
|
+$12.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$22M |
| 2 |
DexCom
DXCM
|
+$13.3M |
| 3 |
Hewlett Packard
HPE
|
+$11.9M |
| 4 |
Apple
AAPL
|
+$8.54M |
| 5 |
Encompass Health
EHC
|
+$7.43M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.48% |
| 2 | Healthcare | 17.52% |
| 3 | Financials | 14.91% |
| 4 | Consumer Discretionary | 13.46% |
| 5 | Communication Services | 11.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$3.76T
| $148M | 8.5% |
728,093
+5,100
| +0.7% | +$926K |
|
|
2
Alibaba
BABA
$317B
| $93.4M | 5.36% |
433,216
+57,900
| +15% | +$12.1M |
|
3
Alphabet (Google) Class A
GOOGL
$4.37T
| $77.1M | 4.42% |
1,086,960
-8,100
| -0.7% | -$546K |
|
|
4
Apple
AAPL
$4.5T
| $65.9M | 3.78% |
722,384
-110,200
| -13% | -$8.54M |
|
5
Amazon
AMZN
$3T
| $43.3M | 2.48% |
313,680
-50,160
| -14% | -$6.06M |
|
6
Adobe
ADBE
$109B
| $42.4M | 2.43% |
97,312
+4,863
| +5% | +$1.8M |
|
7
Visa
V
$675B
| $40.3M | 2.31% |
208,703
-35,883
| -15% | -$6.56M |
|
8
Merck
MRK
$323B
| $38.8M | 2.23% |
525,479
+97,453
| +23% | +$7.34M |
|
9
NVIDIA
NVDA
$5.27T
| $38.7M | 2.22% |
4,076,120
+20,800
| +0.5% | +$168K |
|
10
Thermo Fisher Scientific
TMO
$222B
| $37.3M | 2.14% |
102,840
+2,660
| +3% | +$892K |
|
11
Verizon
VZ
$195B
| $35.6M | 2.04% |
645,447
-35,600
| -5% | -$2M |
|
12
JPMorgan Chase
JPM
$956B
| $34M | 1.95% |
361,591
+2,500
| +0.7% | +$237K |
|
13
Global Payments
GPN
$22.8B
| $32.8M | 1.88% |
193,210
-349
| -0.2% | -$58.1K |
|
14
Colgate-Palmolive
CL
$74.3B
| $32.8M | 1.88% |
447,116
+62,300
| +16% | +$4.43M |
|
15
BioMarin Pharmaceuticals
BMRN
$13.3B
| $32.7M | 1.88% |
265,237
+27,317
| +11% | +$2.71M |
|
16
Prologis
PLD
$132B
| $31M | 1.78% |
331,765
+6,800
| +2% | +$607K |
|
17
Blackrock
BLK
$175B
| $28.9M | 1.66% |
53,114
+9,766
| +23% | +$4.93M |
|
18
Xylem
XYL
$28.3B
| $26.7M | 1.53% |
410,948
+50,300
| +14% | +$3.32M |
|
|
19
Akamai
AKAM
$16.9B
| $25.6M | 1.47% |
238,674
+216,000
| +953% | +$21.7M |
|
|
EA
20
DELISTED
Electronic Arts
EA
| $25.3M | 1.45% |
191,900
+800
| +0.4% | +$94.5K |
|
21
S&P Global
SPGI
$121B
| $25.3M | 1.45% |
76,703
+5,583
| +8% | +$1.68M |
|
22
Walt Disney
DIS
$178B
| $24.6M | 1.41% |
220,743
-9,000
| -4% | -$994K |
|
23
Centene
CNC
$32.9B
| $24.5M | 1.41% |
385,263
+1,300
| +0.3% | +$84.6K |
|
24
Palo Alto Networks
PANW
$314B
| $24M | 1.38% |
627,294
+102,924
| +20% | +$3.63M |
|
25
Sarepta Therapeutics
SRPT
$1.81B
| $22.7M | 1.3% |
141,600
+18,100
| +15% | +$2.46M |
|
Similar funds
IWM
CW
IUHSA
MYIA
NEI
CIC
SLI
E. Ohman J:or Asset Management's Q2 2020 Portfolio in Review
As of Q2 2020, E. Ohman J:or Asset Management held 472 positions worth $1.74B, up 28% from $1.36B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
E. Ohman J:or Asset Management deployed $80.9M of net new capital in Q2 2020, opening 31 new positions and adding to 172 existing holdings. Its largest new stake was NuVasive, Inc.: 269,300 shares worth $15M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $22M trimmed.
- E. Ohman J:or Asset Management's largest Q2 2020 buy was NuVasive, Inc.: 269,300 shares worth $15M.
- E. Ohman J:or Asset Management added most to Akamai in Q2 2020, an estimated $21.7M increase.
- E. Ohman J:or Asset Management's biggest Q2 2020 reduction was Alexion Pharmaceuticals, cutting an estimated $22M.
- E. Ohman J:or Asset Management fully exited NextEra Energy in Q2 2020, selling an estimated $4.21M.
- E. Ohman J:or Asset Management's ten largest holdings make up 36% of its $1.74B portfolio in Q2 2020.
- E. Ohman J:or Asset Management opened 31 new positions and closed 43 in Q2 2020.
- E. Ohman J:or Asset Management's portfolio value rose 28% quarter-over-quarter to $1.74B.
Based on E. Ohman J:or Asset Management's 13F filing for Q2 2020, filed 5 Apr 2024.